Stereotactic Ablative Body Radiotherapy for Lung Cancer

Potters, 2010, American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy, Int J Radiat Oncol Biol Phys, 76, 326, 10.1016/j.ijrobp.2009.09.042 Leksell, 1951, The stereotaxic method and radiosurgery of the brain, Acta Chirug Scand, 102, 316 Lax, 1994, Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects, Acta Oncol, 33, 677, 10.3109/02841869409121782 Blomgren, 1995, Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients, Acta Oncol, 34, 861, 10.3109/02841869509127197 Munzenrider, 1977, Use of body scanner in radiotherapy treatment planning, Cancer, 40, 170, 10.1002/1097-0142(197707)40:1<170::AID-CNCR2820400128>3.0.CO;2-9 Fullerton, 1978, CT determination of parameters for inhomogeneity corrections in radiation therapy of the esophagus, Radiology, 126, 167, 10.1148/126.1.167 Hobday, 1979, Computed tomography applied to radiotherapy treatment planning: techniques and results, Radiology, 133, 477, 10.1148/133.2.477 Babcock, 1984, The value of computed tomography in planning radiotherapy of intra-thoracic tumours, Strahlentherapie, 160, 26 Balter, 1996, Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing, Int J Radiat Oncol Biol Phys, 36, 167, 10.1016/S0360-3016(96)00275-1 Shimizu, 2001, Detection of lung tumor movement in real-time tumor-tracking radiotherapy, Int J Radiat Oncol Biol Phys, 51, 304, 10.1016/S0360-3016(01)01641-8 Smith, 2012, A practical method of identifying data loss in 4DCT, Radiother Oncol, 102, 393, 10.1016/j.radonc.2011.10.002 Salguero, 2013, Microscopic disease extensions as a risk factor for loco-regional recurrence of NSCLC after SBRT, Radiother Oncol, 109, 26, 10.1016/j.radonc.2013.08.028 Shah, 2013, Required target margins for image-guided lung SBRT: assessment of target position intrafraction and correction residuals, Pract Radiat Oncol, 3, 67, 10.1016/j.prro.2012.03.004 Shaw, 1993, Radiation Therapy Oncology Group: radiosurgery quality assurance guidelines, Int J Radiat Oncol Biol Phys, 27, 1231, 10.1016/0360-3016(93)90548-A Franks, 2012 Purdie, 2007, Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: localization, verification, and intrafraction tumor position, Int J Radiat Oncol Biol Phys, 10.1016/j.ijrobp.2006.12.022 Bahig, 2013, Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience, Int J Radiat Oncol Biol Phys, 87, 583, 10.1016/j.ijrobp.2013.06.2048 Hoisak, 2004, Correlation of lung tumor motion with external surrogate indicators of respiration, Int J Radiat Oncol Biol Phys, 60, 1298, 10.1016/j.ijrobp.2004.07.681 Timmerman, 2003, Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer, Chest, 124, 1946, 10.1378/chest.124.5.1946 Timmerman, 2006, Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer, J Clin Oncol, 24, 4833, 10.1200/JCO.2006.07.5937 Hurkmans, 2009, Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study, Radiat Oncol, 4, 1, 10.1186/1748-717X-4-1 Grills, 2012, A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy, J Thorac Oncol, 7, 1382, 10.1097/JTO.0b013e318260e00d Forquer, 2009, Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites, Radiother Oncol, 93, 408, 10.1016/j.radonc.2009.04.018 Chang, 2014, Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a “no fly zone”, Int J Radiat Oncol Biol Phys, 88, 1120, 10.1016/j.ijrobp.2014.01.022 Stephans, 2014, Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity, Int J Radiat Oncol Biol Phys, 90, 197, 10.1016/j.ijrobp.2014.05.011 Senthi, 2013, Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review, Radiother Oncol, 106, 276, 10.1016/j.radonc.2013.01.004 Schanne, 2014, Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysis, Strahlenther Onkol Dunlap, 2010, Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy, Int J Radiat Oncol Biol Phys, 76, 796, 10.1016/j.ijrobp.2009.02.027 Andolino, 2011, Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver, Int J Radiat Oncol Biol Phys, 80, 692, 10.1016/j.ijrobp.2010.03.020 Shaikh, 2014, Predictors and management of chest wall toxicity after lung stereotactic body radiotherapy, Cancer Treat Rev, 10.1016/j.ctrv.2014.09.003 Bongers, 2013, Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs, Radiother Oncol, 109, 95, 10.1016/j.radonc.2013.10.011 Guckenberger, 2010, Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy, Radiother Oncol, 97, 65, 10.1016/j.radonc.2010.04.027 Landreneau, 1997, Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer, J Thorac Cardiovasc Surg, 113, 691, 10.1016/S0022-5223(97)70226-5 Harpole, 1995, Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence, Cancer, 76, 787, 10.1002/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO;2-Q Audit NLC, 2012 Morita, 1997, Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients, Radiother Oncol, 42, 31, 10.1016/S0167-8140(96)01828-2 Armstrong, 1989, Radiation therapy for medically inoperable stage I and II non-small cell lung cancer, Cancer Treat Rev, 16, 247, 10.1016/0305-7372(89)90044-3 Sibley, 1998, Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: smaller volumes and higher doses – a review, Cancer, 82, 433, 10.1002/(SICI)1097-0142(19980201)82:3<433::AID-CNCR2>3.0.CO;2-Q Noordijk, 1988, Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer, Radiother Oncol, 13, 83, 10.1016/0167-8140(88)90029-1 (NICE) NIfHaCE, 2011 Vansteenkiste, 2013, Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 24, vi89, 10.1093/annonc/mdt241 Grutters, 2010, Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis, Radiother Oncol, 95, 32, 10.1016/j.radonc.2009.08.003 Zheng, 2014, Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis, Int J Radiat Oncol Biol Phys, 90, 603, 10.1016/j.ijrobp.2014.05.055 Crabtree, 2010, Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer, J Thorac Cardiovasc Surg, 140, 377, 10.1016/j.jtcvs.2009.12.054 Verstegen, 2013, Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis, Ann Oncol, 24, 1543, 10.1093/annonc/mdt026 Onishi, 2004, Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study, Cancer, 101, 1623, 10.1002/cncr.20539 Guckenberger, 2014, Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer, Strahlenther Onkol, 190, 26, 10.1007/s00066-013-0450-y Zhang, 2011, Which is the optimal biologically effective dose of stereotactic body radiotherapy for stage I non-small-cell lung cancer? A meta-analysis, Int J Radiat Oncol Biol Phys, 81, e305, 10.1016/j.ijrobp.2011.04.034 Senthi, 2012, Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis, Lancet Oncol, 13, 802, 10.1016/S1470-2045(12)70242-5 Consortium US, 2014 Dahele, 2011, Radiological changes after stereotactic radiotherapy for stage I lung cancer, J Thorac Oncol, 6, 1221, 10.1097/JTO.0b013e318219aac5 Bibault, 2013, CT appearance of pulmonary carcinomas after stereotactic radiation therapy, Diagn Intervent Imaging, 94, 255, 10.1016/j.diii.2012.06.006 Lo, 2011, Imaging changes after stereotactic body radiation therapy for lung and liver tumors, Expert Rev Anticancer Ther, 11, 613, 10.1586/era.10.164 Huang, 2012, Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – can we distinguish recurrence from fibrosis? A systematic review of the literature, Radiother Oncol, 102, 335, 10.1016/j.radonc.2011.12.018 Huang, 2013, 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy, J Nucl Med, 54, 1710, 10.2967/jnumed.112.119370 Huang, 2013, High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer, Radiother Oncol, 109, 51, 10.1016/j.radonc.2013.06.047 Widder, 2011, Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer, Int J Radiat Oncol Biol Phys, 81, e291, 10.1016/j.ijrobp.2011.03.052 Lagerwaard, 2012, Patient-reported quality of life after stereotactic ablative radiotherapy for early-stage lung cancer, J Thorac Oncol, 7, 1148, 10.1097/JTO.0b013e318252cfef Nyman, 2014, SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC, Radiother Oncol, 111, 232, 10.1016/S0167-8140(15)30671-X Palma, 2011, Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery, Radiother Oncol, 101, 240, 10.1016/j.radonc.2011.06.029 Friedel, 1999, [Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases – the International Registry of Lung Metastases], Zentralblatt Chirurg, 124, 96 Siva, 2010, Stereotactic radiotherapy for pulmonary oligometastases: a systematic review, J Thorac Oncol, 5, 1091, 10.1097/JTO.0b013e3181de7143 Fumagalli, 2012, A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases, Radiat Oncol, 7, 164, 10.1186/1748-717X-7-164 Milano, 2012, Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study, Int J Radiat Oncol Biol Phys, 83, 878, 10.1016/j.ijrobp.2011.08.036 Widder, 2013, Pulmonary oligometastases: metastasectomy or stereotactic ablative radiotherapy?, Radiother Oncol, 107, 409, 10.1016/j.radonc.2013.05.024 Sim, 2013, PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology, Lung, 191, 625, 10.1007/s00408-013-9500-6